Prevalence of prenatal alcohol exposure in the state of Texas as assessed by phosphatidylethanol in newborn dried blood spot specimens LN Bakhireva, J Sharkis, S Shrestha, TJ Miranda‐Sohrabji, S Williams, ... Alcoholism: Clinical and Experimental Research 41 (5), 1004-1011, 2017 | 74 | 2017 |
Barriers and facilitators to dispensing of intranasal naloxone by pharmacists LN Bakhireva, A Bautista, S Cano, S Shrestha, AM Bachyrycz, TH Cruz Substance abuse 39 (3), 331-341, 2018 | 68 | 2018 |
Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5–8 months of age LN Bakhireva, BD Holbrook, S Shrestha, Y Leyva, M Ashley, S Cano, ... Early human development 128, 69-76, 2019 | 53 | 2019 |
Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery A Bachyrycz, S Shrestha, BE Bleske, D Tinker, LN Bakhireva Substance abuse 38 (1), 55-60, 2017 | 52 | 2017 |
Stability of phosphatidylethanol in dry blood spot cards LN Bakhireva, S Shrestha, HL Gutierrez, M Berry, C Schmitt, D Sarangarm Alcohol and Alcoholism 51 (3), 275-280, 2016 | 46 | 2016 |
Challenges of diagnosing fetal alcohol spectrum disorders in foster and adopted children LN Bakhireva, L Garrison, S Shrestha, J Sharkis, R Miranda, K Rogers Alcohol 67, 37-43, 2018 | 42 | 2018 |
Prevalence of alcohol use in pregnant women with substance use disorder LN Bakhireva, S Shrestha, L Garrison, L Leeman, WF Rayburn, ... Drug and alcohol dependence 187, 305-310, 2018 | 33 | 2018 |
Spatial epidemiology: An empirical framework for syndemics research S Shrestha, CXC Bauer, B Hendricks, TJ Stopka Social Science & Medicine 295, 113352, 2022 | 32 | 2022 |
The effect of prenatal substance use and maternal contingent responsiveness on infant affect J Lowe, F Qeadan, L Leeman, S Shrestha, JM Stephen, LN Bakhireva Early human development 115, 51-59, 2017 | 29 | 2017 |
Ethylglucuronide in maternal hair as a biomarker of prenatal alcohol exposure HL Gutierrez, L Hund, S Shrestha, WF Rayburn, L Leeman, DD Savage, ... Alcohol 49 (6), 617-623, 2015 | 27 | 2015 |
Medical mistrust, discrimination, and COVID-19 vaccine behaviors among a national sample US adults JD Allen, Q Fu, S Shrestha, KH Nguyen, TJ Stopka, A Cuevas, L Corlin SSM-Population Health 20, 101278, 2022 | 24 | 2022 |
The association between prenatal alcohol exposure and protein expression in human placenta BD Holbrook, S Davies, S Cano, S Shrestha, LL Jantzie, WF Rayburn, ... Birth defects research 111 (12), 749-759, 2019 | 24 | 2019 |
Dietary Intake Among Opioid- and Alcohol-Using Pregnant Women JMSLNB Shikhar Shrestha, Elizabeth Jimenez, Laura Garrison, Peter Pribis ... Substance Use and Misuse, 2017 | 22* | 2017 |
Self-regulation and emotional reactivity in infants with prenatal exposure to opioids and alcohol KG Beauchamp, J Lowe, RM Schrader, S Shrestha, C Aragón, N Moss, ... Early human development 148, 105119, 2020 | 16 | 2020 |
Characterizing opioid-involved overdose risk in local communities: An opioid overdose vulnerability assessment across Indiana, 2017 JL Sawyer, S Shrestha, JC Pustz, R Gottlieb, D Nichols, M Van Handel, ... Preventive medicine reports 24, 101538, 2021 | 15 | 2021 |
Governing nested externalities during a pandemic: Social distancing as a coproduction problem V Rayamajhee, S Shrestha, P Paniagua Cosmos and Taxis 9 (5-6), 64-80, 2021 | 15 | 2021 |
Prevalence and correlates of non-fatal overdose among people who use drugs: findings from rapid assessments in Massachusetts, 2017–2019 S Shrestha, TJ Stopka, JMW Hughto, P Case, WR Palacios, B Reilly, ... Harm Reduction Journal 18, 1-12, 2021 | 13 | 2021 |
Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome S Shrestha, MH Roberts, JR Maxwell, LM Leeman, LN Bakhireva Neurotoxicology and teratology 86, 106975, 2021 | 13 | 2021 |
Disparities in breastfeeding outcomes among women with opioid use disorder JM Stephen, S Shrestha, EY Jimenez, SM Williams, A Ortega, S Cano, ... Acta paediatrica (Oslo, Norway: 1992) 109 (5), 1064, 2020 | 5 | 2020 |
Spatial access to buprenorphine-waivered prescribers in the HEALing communities study: enhanced 2-step floating catchment area analyses in Massachusetts, Ohio, and Kentucky S Shrestha, MR Lindstrom, D Harris, P Rock, S Srinivasan, JC Pustz, ... Journal of Substance Use and Addiction Treatment 150, 209077, 2023 | 3 | 2023 |